Interleukin 6, but not ciliary neurotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis

Cytokine

Volumn 10, Issue 6, 1998, Pages 452-456

  Kaibara, Atsushi ^a   Espat, N Joseph ^a   Auffenberg, Troy ^a   Abouhamze, Amer S ^a   Martin, David ^b   Kalra, Satya ^a   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

CNTF; IL 6; LIF; Turpentine induced myositis

Indexed keywords

ALBUMIN; AMYLOID A PROTEIN; AMYLOID P COMPONENT; ANTIBODY; CILIARY NEUROTROPHIC FACTOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; TURPENTINE;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; FEMALE; HYPOALBUMINEMIA; MOUSE; MYOSITIS; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0032101969     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0313     Document Type: Article

References (34)

1. 1. Strassman G, Jacob CO, Evans R, Beau D, Fong M (1992) Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. J Immunol 148:3674.
2. 2. Oldenburg HS, Rogy MA, Lazarus DD, Van Zee KJ, Keeler BP, Chizzonite RA, Lowry SF, Moldawer LL (1993) Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur J Immunol 23:1889.
3. 3. Espat NJ, Auffenberg T, Rosenberg JJ, Rogy M, Martin D, Fang CH, Hasselgren PO, Copeland EM, Moldawer LL (1996) Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response. Am J Physiol 271: R185.
4. 4. Ryffel B (1993) Pathology induced by leukemia inhibitory factor. Int Rev Exp Pathol 34 Pt B:69.
5. 5. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Yancopoulos, GD (1992) CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69:1121.
6. 6. Patterson PH (1992) The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL-6; next ONC, MGF, GCSF? Curr Opin Neurobiol 2:94.
7. 7. Henderson JT, Seniuk NA, Richardson PM, Gauldie J, Roder JC (1994) Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J Clin Invest 93:2632.
8. 8. Ulenkate HJLM, Kaal ECA, Jennekens FGI (1995) Ciliary neurotrophic factor induces hypophagia, hypodipsia, and diminished weight gain in young adult rats. Neurosci Res Commun 16:67.
9. 9. Moldawer LL, Andersson C, Gelin J, Lundholm KG (1988) Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 254:G450.
10. 10. Fong Y, Moldawer LL, Marano M, Wei H, Barber A, Manogue K, Tracey KJ, Kuo G, Fischman DA, Cerami A, Lowry SF (1989) Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 256:R659.
11. 11. Xu B, Dube MG, Kalra PS, Farmerie WG, Kaibara A, Moldawer LL, Martin D, Kalra SP (1998) Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin. Endocrinology 139: 466-473.
12. 12. Baumann H, Ziegler SF, Mosley B, Morella KK, Pajovic S, Gearing DP (1993) Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J Biol Chem 268:8414.
13. 13. Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose John S (1992) Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes. FEBS Lett 314:280.
14. 14. Metcalf D, Gearing DP (1989) Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 86:5948.
15. 15. Kordula T, Rokita H, Koj A, Fiers W, Gauldie J, Baumann H (1991) Effects of interleukin-6 and leukemia inhibitory factor on the acute phase response and DNA synthesis in cultured rat hepatocytes. Lymphokine Cytokine Res 10:23.
16. 16. Lotz M, Moats T, Villiger PM (1992) Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 90:888.
17. 17. Lorenzo JA, Jastrzebski SL, Kalinowski JF, Downie E, Korn JH (1994) Tumor necrosis factor alpha stimulates production of leukemia inhibitory factor in human dermal fibroblast cultures. Clin Immunol Immunopathol 70:260.
18. 18. Campbell IK, Waring P, Novak U, Hamilton JA (1993) Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum 36:790.
19. 19. Shadiack AM, Hart RP, Carlson CD, Jonakait GM (1993) Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF). J Neurosci 13:2601.
20. 20. Waring P, Wycherley K, Cary D, Nicola N, Metcalf D (1992) Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 90:2031.
21. 21. Ballmer PE, McNurlan MA, Southorn BG, Grant I, Garlick PJ (1991) Effects of human recombinant interleukin-1 beta on protein synthesis in rat tissues compared with a classical acute-phase reaction induced by turpentine. Rapid response of muscle to interleukin-1 beta. Biochem J 279:683.
22. 22. Gershenwald JE, Fong YM, Fahey TJ, Calvano SE, Chizzonite R, Kilian PL, Lowry SF, Moldawer LL (1990) Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 87:4966.
23. 23. Oldenburg HS, Pruitt JH, Lazarus DD, Rogy MA, Chizzonite R, Lowry SF, Moldawer LL (1995) Interleukin 1 bindingto its type I, but not type II receptor, modulates the in vivo acute phase response. Cytokine 7:510.
24. 24. Block MI, Berg M, McNamara MJ, Norton JA, Fraker DL, Alexander HR (1993) Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J Exp Med 178:1085.
25. 25. Sherry BA, Gelin J, Fong Y, Marano M, Wei H, Cerami A, Lowry SF, Lundholm KG, Moldawer LL (1989) Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J 3:1956.
26. 26. Gelin J, Moldawer LL, Lonnroth C, Sherry B, Chizzonite R, Lundholm K (1991) Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 51:415.
27. 27. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, Sipe JD, Shaw AR, Dinarello CA (1996) Effect of endotoxin in IL-I beta-deficient mice. J Immunol 157:291.
28. 28. Fantuzzi G, Dinarello CA (1996) The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. J Leukoc Biol 59:489.
29. 29. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
30. 30. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, Faggioni R, Fantuzzi G, Ghezzi P, Poli V (1994) Defective inflammatory response in interleukin-6 deficient mice. J Exp Med 180:1243.
31. 31. Block MI, Fraker DL, Strassmann G, Billingsley KG, Arnold WS, Perlis C, Alexander HR (1995) Endogenous D-factor activity partially mediates the toxic but not the therapeutic effects of tumor necrosis factor. Int J Cancer 63:245.
32. 32. Alexander HR, Wong GG, Doherty GM, Venzon DJ, Fraker DL, Norton JA (1992) Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor. J Exp Med 175:1139.
33. 33. McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Kilian PL (1991) Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173:931.
34. 34. Hellerstein MK, Sasak V, Ordovas J, Munro HN (1985) Isolation of alpha 1-acid gylcoprotein from human plasma using high-performance liquid chromatography. Analytical Biochemistry 146:366.